Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea
· Delayed Price · Currency is KRW 6,550.00
+50.00 (0.77%)
At close: Jun 5, 2025, 3:30 PM KST
Dongwha Pharm.Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 471,663 | 464,875 | 361,109 | 340,426 | 293,018 | 272,075 | Upgrade
|
| Other Revenue | - | - | - | -0 | - | - | Upgrade
|
| Revenue | 471,663 | 464,875 | 361,109 | 340,426 | 293,018 | 272,075 | Upgrade
|
| Revenue Growth (YoY) | 23.94% | 28.73% | 6.08% | 16.18% | 7.70% | -11.42% | Upgrade
|
| Cost of Revenue | 257,403 | 250,617 | 170,693 | 159,436 | 143,671 | 133,409 | Upgrade
|
| Gross Profit | 214,260 | 214,258 | 190,416 | 180,990 | 149,347 | 138,666 | Upgrade
|
| Selling, General & Admin | 167,473 | 165,146 | 142,338 | 125,515 | 103,217 | 92,288 | Upgrade
|
| Research & Development | 23,811 | 23,599 | 21,548 | 19,285 | 17,338 | 16,912 | Upgrade
|
| Other Operating Expenses | 2,391 | 2,362 | 2,291 | 1,993 | 1,808 | 1,930 | Upgrade
|
| Operating Expenses | 205,118 | 200,847 | 171,750 | 151,075 | 126,848 | 115,588 | Upgrade
|
| Operating Income | 9,142 | 13,411 | 18,666 | 29,915 | 22,499 | 23,078 | Upgrade
|
| Interest Expense | -2,611 | -2,152 | -308.01 | -370 | -383.11 | -292.15 | Upgrade
|
| Interest & Investment Income | 2,153 | 2,491 | 6,683 | 2,493 | 1,744 | 1,840 | Upgrade
|
| Earnings From Equity Investments | 0 | -219.37 | 2,420 | -2,269 | -410.4 | -114.11 | Upgrade
|
| Currency Exchange Gain (Loss) | -827.06 | -460.25 | 377.78 | 31.87 | 687.36 | -499.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 852.03 | 566.8 | 145.65 | 527.55 | 630.9 | -357.6 | Upgrade
|
| EBT Excluding Unusual Items | 8,710 | 13,637 | 27,985 | 30,328 | 24,768 | 23,655 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5,478 | -6,435 | 9,434 | -4,506 | 1,801 | 2,561 | Upgrade
|
| Gain (Loss) on Sale of Assets | 27.62 | 21.1 | 28.76 | 741.89 | 169.46 | 7,462 | Upgrade
|
| Asset Writedown | -321.29 | -321.16 | -491.98 | -3,478 | -316.08 | -39.91 | Upgrade
|
| Other Unusual Items | - | - | - | - | 105.41 | - | Upgrade
|
| Pretax Income | 2,938 | 6,902 | 36,956 | 23,086 | 26,527 | 33,638 | Upgrade
|
| Income Tax Expense | 4,517 | 4,756 | 8,719 | 1,494 | 6,944 | 4,923 | Upgrade
|
| Earnings From Continuing Operations | -1,579 | 2,146 | 28,237 | 21,591 | 19,583 | 28,715 | Upgrade
|
| Minority Interest in Earnings | 4,189 | 3,417 | -798.76 | -1,208 | -1,712 | -207.41 | Upgrade
|
| Net Income | 2,610 | 5,563 | 27,438 | 20,383 | 17,870 | 28,508 | Upgrade
|
| Net Income to Common | 2,610 | 5,563 | 27,438 | 20,383 | 17,870 | 28,508 | Upgrade
|
| Net Income Growth | -85.41% | -79.72% | 34.61% | 14.06% | -37.31% | 212.72% | Upgrade
|
| Shares Outstanding (Basic) | 29 | 28 | 28 | 28 | 28 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 28 | 28 | 28 | 28 | 28 | Upgrade
|
| Shares Change (YoY) | 6.15% | 0.12% | 0.02% | 0.16% | 0.05% | 0.05% | Upgrade
|
| EPS (Basic) | 88.81 | 200.71 | 991.07 | 736.42 | 646.68 | 1032.60 | Upgrade
|
| EPS (Diluted) | 88.81 | 200.71 | 991.07 | 736.42 | 646.68 | 1032.51 | Upgrade
|
| EPS Growth | -86.26% | -79.75% | 34.58% | 13.88% | -37.37% | 212.88% | Upgrade
|
| Free Cash Flow | -60,945 | -40,689 | 4,626 | 10,792 | 14,087 | 17,982 | Upgrade
|
| Free Cash Flow Per Share | -2074.07 | -1467.95 | 167.09 | 389.91 | 509.78 | 651.02 | Upgrade
|
| Dividend Per Share | 180.000 | 180.000 | 180.000 | 180.000 | 180.000 | 180.000 | Upgrade
|
| Gross Margin | 45.43% | 46.09% | 52.73% | 53.17% | 50.97% | 50.97% | Upgrade
|
| Operating Margin | 1.94% | 2.89% | 5.17% | 8.79% | 7.68% | 8.48% | Upgrade
|
| Profit Margin | 0.55% | 1.20% | 7.60% | 5.99% | 6.10% | 10.48% | Upgrade
|
| Free Cash Flow Margin | -12.92% | -8.75% | 1.28% | 3.17% | 4.81% | 6.61% | Upgrade
|
| EBITDA | 29,900 | 33,080 | 32,562 | 42,424 | 34,591 | 33,785 | Upgrade
|
| EBITDA Margin | 6.34% | 7.12% | 9.02% | 12.46% | 11.80% | 12.42% | Upgrade
|
| D&A For EBITDA | 20,758 | 19,669 | 13,896 | 12,509 | 12,093 | 10,707 | Upgrade
|
| EBIT | 9,142 | 13,411 | 18,666 | 29,915 | 22,499 | 23,078 | Upgrade
|
| EBIT Margin | 1.94% | 2.89% | 5.17% | 8.79% | 7.68% | 8.48% | Upgrade
|
| Effective Tax Rate | 153.74% | 68.91% | 23.59% | 6.47% | 26.18% | 14.64% | Upgrade
|
| Advertising Expenses | - | 48,368 | 41,140 | 34,455 | 29,889 | 27,532 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.